Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
50 participants
OBSERVATIONAL
2020-07-20
2020-09-07
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Protocol of Reintroduction of Beta-lactams in Children at Low Risk of Anaphylaxis.
NCT03553251
Visual Recognition of Allergens by Allergic Patients and/or Their Parents
NCT02966938
Children With Aluminium Contact Allergy: Cutaneous Exposure Study
NCT04438135
Allergen Provocations- HCA Children's Hospital
NCT04331522
Comparison of Skin Prick Testing and Intradermal Skin Test Result of Local and Imported Insect Allergen Extracts
NCT03645291
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
* description of allergic reactions to almond (symptoms, severity)
* modelisation of eliciting dose to almond in our population
* evaluation of the association between atopic comorbidities and allergy to almond in children sensitized to almond
* evaluation of the association between allergy to almond and the importance of skin and sIgE sensitization
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
skin prick-test
retrospective study on data already collected
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
1 Year
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Central Hospital, Nancy, France
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2020PI100
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.